The company’s presence in Copenhagen positions Controlant to tap into Denmark’s strong life-science ecosystem, get closer to its customers, access a large pool of skilled professionals, and more closely collaborate with technology and industry partners, it states.

Controlant is on a growth journey driven. With over 430 people from more than 40 different countries, the company has more than doubled in size over the past 18 months. The new office in Copenhagen is the most recent addition to the company’s growing global operations which span offices in Iceland, Poland, the United States, the Netherlands, and now Denmark.

Read more: Advanced visibility for the life science supply chain – NLS’s interview with Controlant

“Controlant is growing fast, and we have ambitious goals to make pharma supply chains around the world agile, resilient, and sustainable so that medicines and vaccines reach the people who need them, with zero-waste. To ensure we are fully prepared for the journey ahead, we are expanding globally, and have established an office in Copenhagen—a strategic location with close proximity to some of the world’s leading pharmaceutical companies and logistics providers. Close collaboration with our industry partners will play a critical role in digitizing, automating, and ultimately, transforming global pharma supply chains,” says Gísli Herjólfsson, CEO and co-founder of Controlant.

Tapping into Denmark’s strong life-science ecosystem

In Denmark, Controlant employs people across various functions with plans for further expansion with a focus on strategic commercial growth, the company states.

“We are thrilled to be in the Danish capital, a premier location for high-tech activities. By tapping into Denmark’s strong life-science ecosystem, we can connect with many of our current and future customers in the global pharma industry who have major operations or European headquarters in Copenhagen. We feel welcome in Denmark and look forward to growing our team, bringing on board some of the world-class talent based in Denmark,” says Martin Thaysen, Chief Commercial Officer of Controlant .

“We are pleased to support Controlant both in establishing activities in Denmark and with their future growth journey. Besides jobs and growth, Controlant brings life-saving innovation to the Danish life science ecosystem and is a prime example of how an ambitious and persistent focus on sustainability and diversity contributes to a successful business. This is a great match with Danish values, and I am convinced Controlant will find like-minded, top-performing talent and benefit from highly competitive Danish framework conditions,” says Anne Hougaard Jensen, Director of Invest in Denmark.

Featured photo of Gísli Herjólfsson, co-founder and CEO of Controlant attended the opening along with representatives from Invest in Denmark, Copenhagen Capacity, and the Icelandic embassy in Copenhagen, as well customers, partners, investors, members of the board, and employees. Photo: Controlant